Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

July/August 2016

Feature

Perspectives
In Defense of Meaningful Use: The Potential of Electronic Health Records Systems to Support Value-Based Care
08/02/2016
George A Gellert, MD, MPH, MPA
George S Conklin
S Luke Webster, MD
John A Gillean, MD
Lynn A Gibson
Abstract: The Meaningful Use Incentive Program from the Centers for Medicare & Medicaid Services (CMS) has successfully driven the adoption of electronic health records (EHRs). However, it has been criticized...
Abstract: The Meaningful Use Incentive Program from the Centers for Medicare & Medicaid Services (CMS) has successfully driven the adoption of electronic health records (EHRs). However, it has been criticized...
...
08/02/2016
Journal of Clinical Pathways
Perspectives
Frameworks for Assessing the Value of Cancer Drugs: Purely an Academic Exercise?
08/02/2016
Joshua P Cohen, PhD
Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...
Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...
...
08/02/2016
Journal of Clinical Pathways

Column

Pharma Insights
The Rising Use of Oncology Value Tools By Payers
08/02/2016
Jeremy Schafer, PharmD, MBA
Kellie Rademacher, PharmD
Janet Serluco, MS
Attributing value in the rapidly expanding oncology space is a new challenge to payers looking to introduce a range of novel therapies where older drugs have long dominated. Rising costs across all levels of cancer...
Attributing value in the rapidly expanding oncology space is a new challenge to payers looking to introduce a range of novel therapies where older drugs have long dominated. Rising costs across all levels of cancer...
...
08/02/2016
Journal of Clinical Pathways
Clinical Pathways GPS
Impact of Quality of Life on Clinical Pathways
08/02/2016
Jill Cantelmo, DPhil, MSc
Seth Gordon, MBA
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
For clinical pathway developers seeking to define the value of different treatments, quality-of-life (QOL) measures offer a means of capturing the factors that most define value to the patient and their caregivers....
For clinical pathway developers seeking to define the value of different treatments, quality-of-life (QOL) measures offer a means of capturing the factors that most define value to the patient and their caregivers....
For...
08/02/2016
Journal of Clinical Pathways

Department

Conference Preview
Shaping the Pathways of the Future
08/02/2016
JCP Editors
The Inaugural Clinical Pathways Congress September 16-18, 2016; Boston, MA As US expenditures on cancer-related treatments continue to grow, new solutions for managing these costs have increasingly become...
The Inaugural Clinical Pathways Congress September 16-18, 2016; Boston, MA As US expenditures on cancer-related treatments continue to grow, new solutions for managing these costs have increasingly become...
The...
08/02/2016
Journal of Clinical Pathways
Research in Review
Radiotherapy Use and Effectiveness in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
08/02/2016
JCP Editors
A study of adjuvant chemoradiotherapy (CRT) and boost doses of postoperative radiotherapy (B-PORT) in oropharyngeal squamous cell carcinoma (OSCC) has found that outcomes depend on a number of pathologic and...
A study of adjuvant chemoradiotherapy (CRT) and boost doses of postoperative radiotherapy (B-PORT) in oropharyngeal squamous cell carcinoma (OSCC) has found that outcomes depend on a number of pathologic and...
...
08/02/2016
Journal of Clinical Pathways
Research in Review
Prostate Cancer Outcomes Differ Widely Based on Radiation Therapy Choice
08/02/2016
JCP Editors
Patient outcomes differed widely based on which radiation therapy (RT) option was used to treat prostate cancer, according to a study published in Cancer Treatment Reviews. Treatment for prostate cancer, a prevalent...
Patient outcomes differed widely based on which radiation therapy (RT) option was used to treat prostate cancer, according to a study published in Cancer Treatment Reviews. Treatment for prostate cancer, a prevalent...
...
08/02/2016
Journal of Clinical Pathways
Research in Review
Addressing the Unsustainable Growth of Metastatic Cancer Costs
08/02/2016
JCP Editors
Steps must be taken to address the unsustainable growth of health care costs for metastatic cancer in order to better serve patients while still acknowledging the limits of health care resources, claims a review...
Steps must be taken to address the unsustainable growth of health care costs for metastatic cancer in order to better serve patients while still acknowledging the limits of health care resources, claims a review...
Steps...
08/02/2016
Journal of Clinical Pathways
Research in Review
Pathways for Chronic Kidney Disease Diverse and Inconsistent
08/02/2016
JCP Editors
A scoping review published in Nephrology Dialysis Transplantation has found that clinical pathways for chronic kidney disease (CKD) are diverse in their design, content, and implementation. This information may...
A scoping review published in Nephrology Dialysis Transplantation has found that clinical pathways for chronic kidney disease (CKD) are diverse in their design, content, and implementation. This information may...
...
08/02/2016
Journal of Clinical Pathways

News

Conference Coverage
American Society of Clinical Oncology Annual Meeting
08/02/2016
JCP Editors
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, a session was held on the first day dedicated to the topic of clinical pathways in oncology. The session, titled “Practicing in the Age of...
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, a session was held on the first day dedicated to the topic of clinical pathways in oncology. The session, titled “Practicing in the Age of...
At the...
08/02/2016
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

July 2016 Volume 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement